RxSight Raises FY24 Revenue Forecast From $132M - $137M To $139M - $140M, Est $135.071M
Portfolio Pulse from Benzinga Newsdesk
RxSight has raised its FY24 revenue forecast to $139M - $140M, up from the previous estimate of $132M - $137M, surpassing the consensus estimate of $135.071M. Operating expenses are also expected to increase to $135M - $136M, up from the prior guidance of $126M - $130M, due to higher non-cash stock-based compensation expenses.
August 05, 2024 | 9:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RxSight has increased its FY24 revenue forecast to $139M - $140M, exceeding the consensus estimate of $135.071M. However, operating expenses are also expected to rise significantly due to higher non-cash stock-based compensation expenses.
The increase in revenue forecast is a positive indicator for RxSight's financial health and growth prospects, likely boosting investor confidence. However, the rise in operating expenses, particularly due to higher stock-based compensation, may temper some of the enthusiasm. Overall, the net impact is likely positive in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100